Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK
Nicardipine 10 mg/10 ml solution for injection.
| Pharmaceutical Form |
|---|
|
Clear, pale yellow colour solution for injection. |
Each mL of solution contains 1mg of Nicardipine hydrochloride.
Each 10mL ampoule contains 10mg of Nicardipine hydrochloride
Excipient with known effect:
This medicinal product contains sodium.
Each mL of solution for injection contains 0.039 mg equivalent to 0.0017 mmol of sodium.
Each 10 mL ampoule contains 0.39 mg equivalent to 0.017 mmol of sodium.
Each mL of solution for injection contains 50mg sorbitol.
Each 10mL ampoule contains 500 mg sorbitol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nicardipine |
Nicardipine is a second generation slow calcium channel inhibitor, and belongs to the phenyl-dihydropyridine group. Nicardipine has a greater selectivity for L-type calcium channels in vascular smooth muscle than cardiac myocytes. Nicardipine produces smooth muscle relaxation and marked peripheral vasodilatation. |
| List of Excipients |
|---|
|
Sorbitol |
10 ml in a type I brown glass ampoule with an OPC (One Point Cut) break system. Boxes of 5, 10 or 50 ampoules.
Not all pack sizes may be marketed.
Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK
PL 12762/0450
24/04/2014
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
